ProAssurance Co. (NYSE:PRA – Get Free Report) was the target of a large decline in short interest in the month of November. As of November 15th, there was short interest totalling 680,600 shares, a decline of 28.0% from the October 31st total of 945,100 shares. Based on an average trading volume of 260,200 shares, the short-interest ratio is presently 2.6 days. Currently, 1.4% of the shares of the company are sold short.
Analysts Set New Price Targets
A number of analysts have recently weighed in on PRA shares. StockNews.com lowered shares of ProAssurance from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Piper Sandler downgraded ProAssurance from an “overweight” rating to a “neutral” rating and set a $18.00 price target on the stock. in a research report on Monday, November 11th. Finally, Truist Financial boosted their price objective on ProAssurance from $14.00 to $18.00 and gave the company a “hold” rating in a report on Tuesday, November 12th. Three research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $18.67.
Check Out Our Latest Stock Report on PRA
Institutional Inflows and Outflows
ProAssurance Stock Performance
Shares of NYSE:PRA traded down $0.01 during trading on Friday, hitting $16.72. 130,985 shares of the stock traded hands, compared to its average volume of 258,265. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 0.35. The company has a fifty day moving average price of $15.58 and a two-hundred day moving average price of $13.86. ProAssurance has a 52-week low of $10.76 and a 52-week high of $17.79. The company has a market cap of $855.40 million, a price-to-earnings ratio of 20.14 and a beta of 0.24.
ProAssurance Company Profile
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Further Reading
- Five stocks we like better than ProAssurance
- Energy and Oil Stocks Explained
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- Where Do I Find 52-Week Highs and Lows?
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- Stock Average Calculator
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for ProAssurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProAssurance and related companies with MarketBeat.com's FREE daily email newsletter.